Brain magnetic resonance imaging characteristics in dogs and cats with congenital portosystemic shunts

Veterinary Radiology and Ultrasound

Volumn 46, Issue 6, 2005, Pages 447-451

  Torisu, Shidow ^a   Washizu, Makoto ^a   Hasegawa, Daisuke ^a   Orima, Hiromitsu ^a  

^a NIPPON VETERINARY AND LIFE SCIENCE UNIVERSITY   (Japan)

Author keywords

Hyperintensity; Magnetic resonance image; Portosystemic shunt

Indexed keywords

ANIMAL; ANIMAL DISEASE; ARTICLE; BRAIN; CAT; CLASSIFICATION; CONGENITAL MALFORMATION; DOG; FEMALE; HEPATIC ENCEPHALOPATHY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PORTOSYSTEMIC ANASTOMOSIS;

ANIMALS; BRAIN; CATS; DOGS; FEMALE; HEPATIC ENCEPHALOPATHY; MAGNETIC RESONANCE IMAGING; MALE; PORTASYSTEMIC SHUNT, SURGICAL;

ANIMALIA; CANIS FAMILIARIS;

EID: 30944465551     PISSN: 10588183     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1740-8261.2005.00082.x     Document Type: Article

References (20)

1. James JH, Ziparo V, JepCPSSon B, Fischer JE. Hyperammonaemia, plasma aminoacid imbalance, and blood-brain aminoacid transport: a unified theory of portal-systemic encephalopathy. Lancet 1979;13:772-775.
2. Fischer JE, Funovics JM, Aguirre A, et al. The role of plasma amino acids in hepatic encephalopathy. Surgery 1975;78:276-290.
3. Laccetti M, Manes G, Uomo G, Lioniello M, Rabitti PG, Balzano A. Flumazenil in the treatment of acute hepatic encephalopathy in cirrhotic patients: a double blind randomized placebo controlled study. Dig Liver Dis 2000;32:335-338.
4. Meyer HP, Legemate DA, van den Brom W, Rothuizen J. Improvement of chronic hepatic encephalopathy in dogs by the benzodiazepine-receptor partial inverse agonist sarmazenil, but not by the antagonist flumazenil. Metab Brain Dis 1998;13:241-251.
5. Camicioli R, Moore MM, Kinney A, Corbridge E, Glassberg K, Kaye JA. Parkinson's disease is associated with hippocampal atrophy. Mov Disord 2003;18:784-790.
6. Almeida OP, Burton EJ, McKeith I, Gholkar A, Burn D, O'Brien JT. MRI study of caudate nucleus volume in Parkinson's disease with and without dementia with Lewy bodies and Alzheimer's disease. Dement Geriatr Cogn Disord 2003;16:57-63.
7. Gupta RK, Dhiman RK. Magnetic resonance imaging and spectroscopy in hepatic encephalopathy. Indian J Gastroenterol 2003;22(Suppl 2):S45-S49.
8. Hooper PT. Spongy degeneration in the central nervous system of domestic animals. Part III: occurrence and pathogenesis hepatocerebral disease caused by hyperammonaemia. Acta Neuropathol (Berlin) 1975;31:343-351.
9. Herden C, Beineke A, Hetzel U, Lemmer W, Baumgartner W. Unusual manifestation of hepatic encephalopathy in two Irish wolfhound siblings. Vet Rec 2003;153:682-686.
10. Cho DY, Leipold HW. Experimental spongy degeneration in calves. Acta Neuropathol (Berlin) 1977;39:115-127.
11. Layrargues GP. Movement dysfunction and hepatic encephalopathy. Metab Brain Dis 2001;16:27-35.
12. Layrargues GP, Shapcott D, Spahr L, Butterworth RF. Accumulation of manganese and copper in pallidum of cirrhotic patients: role in the pathogenesis of hepatic encephalopathy? Metab Brain Dis 1995;10:353-356.
13. Mizoguchi N, Nishimura Y, Ono H, Sakura N. Manganese elevations in blood of children with congenital portosystemic shunts. Eur J Pediatr 2001;160:247-250.
14. Ikeda S, Sera Y, Yoshida M, et al. Manganese deposits in patients with biliary atresia after hepatic porto-enterostomy. J Pediatr Surg 2000;35:450-453.
15. Lucchini R, Albini E, Placidi D, et al. Brain magnetic resonance imaging and manganese exposure. Neurotoxicology 2000;21:769-775.
16. Fell JM, Reynolds AP, Meadows N, et al. Manganese toxicity in children receiving long-term parenteral nutrition. Lancet 1996;347:1218-1221.
17. 2: a potential alternative to IV injection for tissue contrast enhancement in magnetic resonance imaging. Magn Reson Imaging 1984;2:307-314.
18. Cory DA, Schwartzentruber DJ, Mock BH. Ingested manganese chloride as a contrast agent for magnetic resonance imaging. Magn Reson Imaging 1987;5:65-70.
19. Fornasiero D, Bellen JC, Baker RJ, Chatterton BE. Paramagnetic complexes of manganese (II), iron (III), and gadolinium (III) as contrast agents for magnetic resonance imaging. The influence of stability constants on the biodistribution of radioactive aminopolycarboxylate complexes. Invest Radiol 1987;22:322-327.
20. Lin YJ, Koretsky AP. Manganese ion enhances T1-weighted MRI during brain activation: an approach to direct imaging of brain function. Magn Reson Med 1997;38:378-388.